N,N-Dimethyltryptamine (DMT) is a naturally occurring psychedelic tryptamine found throughout the plant kingdom and in trace amounts in mammalian tissue, including the human brain — a fact that has fueled decades of speculation about its endogenous role in consciousness. When smoked or vaporized, DMT is among the most potent and rapid-onset psychedelic substances known: within 15–60 seconds of inhalation, a full-dose experience transports the user into what is consistently described as a completely separate dimension of reality, populated by complex geometric structures, light, and frequently, autonomous entities — the so-called "machine elves" or "DMT beings" first described by Terence McKenna. The entire experience resolves within 15–30 minutes, leaving the user back in ordinary reality with little residual effect.
Orally, DMT is inactive without a monoamine oxidase inhibitor (MAOI), because gut enzymes (MAO-A) rapidly degrade it. The Amazonian ceremonial brew ayahuasca combines DMT-containing plants with MAOI-containing plants (typically Banisteriopsis caapi vine), enabling oral activity and extending the duration to 4–6 hours. This tradition is thousands of years old and has driven a contemporary spiritual tourism industry and increasing interest from Western researchers studying ayahuasca's potential for treating depression, addiction, and PTSD.
DMT's pharmacology centers on 5-HT2A receptor agonism — the same target as LSD and psilocybin — but its effects are characterized by a speed, completeness, and geometric specificity unlike any other compound. Users consistently across cultures and decades describe the same core phenomena: entry into an alternate space, geometric architecture of extreme complexity and beauty, and contact with entities that feel independently real and communicative. The consistency of these reports across cultures, decades, and independent users has made DMT central to contemporary discussions of consciousness, its neural basis, and the possible existence of non-ordinary states of consciousness as meaningful targets of inquiry.
The risks of DMT are primarily psychological and contextual rather than physiological. Its acute physiological toxicity is very low. The primary risks are: experiencing overwhelming psychological content without adequate preparation, a physically dangerous environment during the incapacitated period, and — relevant to ayahuasca — the serious drug interaction risk if combined with MAOIs (including those in ayahuasca) and other serotonergic medications.
